SEC Form 4 · accession 0001209191-18-015306
HERBALIFE LTD. · HLF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jossie Aspauza
Officer — VP, SAM/CAM
Period of report
Feb 28, 2018
Accepted (ET)
Mar 1, 2018 · 8:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001180262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 28, 2018 | M | 2,512 | $79.58 | A | 14,592 | D | |
| Common Stock | Feb 28, 2018 | D | 2,171 | $92.10 | D | 12,421 | D | |
| Common Stock | Feb 28, 2018 | F | 103 | $92.10 | D | 12,318 | D | |
| Common Stock | Feb 28, 2018 | M | 3,752 | $59.98 | A | 16,070 | D | |
| Common Stock | Feb 28, 2018 | D | 2,444 | $92.10 | D | 13,626 | D | |
| Common Stock | Feb 28, 2018 | F | 393 | $92.10 | D | 13,233 | D | |
| Common Stock | Feb 28, 2018 | M | 1,048 | $62.51 | A | 14,281 | D | |
| Common Stock | Feb 28, 2018 | D | 712 | $92.10 | D | 13,569 | D | |
| Common Stock | Feb 28, 2018 | F | 102 | $92.10 | D | 13,467 | D | |
| Common Stock | Feb 28, 2018 | M | 1,102 | $57.19 | A | 14,569 | D | |
| Common Stock | Feb 28, 2018 | D | 685 | $92.10 | D | 13,884 | D | |
| Common Stock | Feb 28, 2018 | F | 126 | $92.10 | D | 13,758 | D | |
| Common StockF5 | Feb 28, 2018 | S | 9,995 | $90.38 | D | 3,763 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation Rights | $79.58 | Feb 28, 2018 | M | 2,512 | D | Jun 21, 2016 | Dec 19, 2023 | Common Stock | 2,512 | 0 | D |
| Stock Appreciation Rights | $59.98 | Feb 28, 2018 | M | 3,752 | D | Apr 30, 2017 | Apr 30, 2024 | Common Stock | 3,752 | 0 | D |
| Stock Appreciation RightsF6 | $62.51 | Feb 28, 2018 | M | 1,048 | D | May 9, 2017 | May 9, 2026 | Common Stock | 1,048 | 4,192 | D |
| Stock Appreciation RightsF7 | $57.19 | Feb 28, 2018 | M | 1,102 | D | Feb 27, 2018 | Feb 27, 2027 | Common Stock | 1,102 | 4,406 | D |
Explanation of responses
- F1The reporting person received 238 shares of common stock upon the net exercise of 2,512 stock appreciation rights ("SARs"). The reporting person forfeited 2,171 shares of common stock underlying the SARs in payment of the exercise price and 103 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
- F2The reporting person received 915 shares of common stock upon the net exercise of 3,752 SARs. The reporting person forfeited 2,444 shares of common stock underlying the SARs in payment of the exercise price and 393 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
- F3The reporting person received 234 shares of common stock upon the net exercise of 1,048 SARs. The reporting person forfeited 712 shares of common stock underlying the SARs in payment of the exercise price and 102 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
- F4The reporting person received 291 shares of common stock upon the net exercise of 1,102 SARs The reporting person forfeited 685 shares of common stock underlying the SARs in payment of the exercise price and 126 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
- F5This transaction was executed in multiple trades at prices ranging from $90.11 to $90.65. The price reported reflects the weighted average sale price of $90.38. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6Consists of stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested May 9, 2017, and 20% will vest on May 9, 2018, and the remaining 60% will vest May 9, 2019.
- F7Consists of stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested February 27, 2018, 20% will vest February 27, 2019, and the remaining 60% will vest February 27, 2020.